"FastWave's novel approach has enormous potential to leapfrog today's IVL technology with durable, fast, and consistent laser energy," says Dr. William Nicholson. "It also enables FastWave's team of engineers to develop an ultra-sleek balloon...
"FastWave's novel approach has enormous potential to leapfrog today's IVL technology with durable, fast, and consistent laser energy," says Dr. William Nicholson. "It also enables FastWave's team of engineers to develop an ultra-sleek balloon...
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, announced it has treated the first large bore venous patient with the PerQseal® Elite vascular closure system, a sutureless and fully...
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, announced it has treated the first large bore venous patient with the PerQseal® Elite vascular closure system, a sutureless and fully...
Brigham and Women's Hospital / Boston Medical Center News
Brigham and Women's Hospital / Boston...
“Our study indicates that patients with CLTI have a notably poor quality of life – substantially lower than with many other chronic conditions,” said Matthew Menard, MD. “Our findings show that revascularization significantly improves quality...
“Our study indicates that patients with CLTI have a notably poor quality of life – substantially lower than with many other chronic conditions,” said Matthew Menard, MD. “Our findings show that revascularization significantly improves quality...
Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB) addressing peripheral vascular stents.
Aetna issued a revised CPB stating that the iCast covered stent...
Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB) addressing peripheral vascular stents.
Aetna issued a revised CPB stating that the iCast covered stent...
Long-term durability data showed clinically meaningful, safe and sustained blood pressure (BP) reductions (-23.2 mmHg in office systolic BP and -14.0 mmHg reductions in 24-hour ambulatory BP) in patients with uncontrolled hypertension.
Long-term durability data showed clinically meaningful, safe and sustained blood pressure (BP) reductions (-23.2 mmHg in office systolic BP and -14.0 mmHg reductions in 24-hour ambulatory BP) in patients with uncontrolled hypertension.
The CERAB technique (covered endovascular reconstruction of the aortic bifurcation) in combination with the BeGraft aortic and two BeGraft peripheral stents provide a treatment option especially for high-risk patients for whom open surgery is...
The CERAB technique (covered endovascular reconstruction of the aortic bifurcation) in combination with the BeGraft aortic and two BeGraft peripheral stents provide a treatment option especially for high-risk patients for whom open surgery is...
Study author Dr. Ki Hong Lee of Chonnam National University Hospital, Gwangju, Republic of Korea said: “Patients with diabetes tend to put pressure on the metatarsal area of the foot, rather than the heel. This way of walking encourages...
Study author Dr. Ki Hong Lee of Chonnam National University Hospital, Gwangju, Republic of Korea said: “Patients with diabetes tend to put pressure on the metatarsal area of the foot, rather than the heel. This way of walking encourages...
Johnson & Johnson and Shockwave Medical, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash, corresponding to an...
Johnson & Johnson and Shockwave Medical, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash, corresponding to an...
Join us for a Comprehensive Review of Cardiovascular Medicine to 20+ CMEs
NEW ORLEANS –Bringing physicians from around the world together for a comprehensive review of cardiovascular medicine, the 25th annual New Cardiovascular Horizons...
Join us for a Comprehensive Review of Cardiovascular Medicine to 20+ CMEs
NEW ORLEANS –Bringing physicians from around the world together for a comprehensive review of cardiovascular medicine, the 25th annual New Cardiovascular Horizons...
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission
VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health,...
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission
VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health,...